10 articles with BioAgilytix Labs
BioAgilytix Launches Customizable Testing Packages Supporting Solutions to Treat and Prevent Spread of COVID-19
The CRO has applied its clinical assay and diagnostics capabilities to address a breadth of sponsor and employer needs stemming from the COVID-19 pandemic
Inc. magazine collates an annual list of the fastest-growing private companies in America. This year, 15 of the top 5,000 were related to healthcare, medical devices and biopharma.
Bioasis and BioAgilytix Announce Strategic Collaboration to Advance xB3 TM-001, Bioasis’ Lead Investigational Candidate to Treat HER2+ Brain Cancer, to IND Submission and into the Clinic
Bioasis and BioAgilytix today announced a strategic collaboration to partner on the development and validation of bioanalytical methods to support and advance the xB3 TM-001 program.
Subject matter experts to share latest advancements in drug discovery and development
American Type Culture Collection (ATCC) And BioAgilytix Labs Announce Partnership To Develop Custom Cell-Based Assay Solutions To Support Biopharmaceutical R&D
Riverside Partners' Portfolio Company, BioAgilytix Labs, Accelerates Global Expansion With The Acquisition Of German Player, IPM Biotech
BioAgilytix Labs Announces Acquisition Of European-Based IPM Biotech To Expand And Enhance The Global Reach And Breadth Of Their Best-Of-Breed Bioanalytical Capabilities